Number of the records: 1
cilostazol
SYS d000077407 LBL 00000nz--a2200181n--4500 005 20250606222646.8 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D03.383.129.617.293 065 $a D03.633.100.810.069 066 $a 01 $c 03 150 $a cilostazol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a OPC 13013 $2 slo 450 $w v $a Pletal $2 slo 450 $w v $a 6-(4-(1-cyklohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-chinolinón $2 slo 550 $7 sllk_us_auth*d001993 $Y Bronchodilator Agents $w P $a látky bronchodilatačné 550 $7 sllk_us_auth*d005343 $Y Fibrinolytic Agents $w P $a fibrinolytiká 550 $7 sllk_us_auth*d010975 $Y Platelet Aggregation Inhibitors $w P $a inhibítory agregácie trombocytov 550 $7 sllk_us_auth*d014665 $Y Vasodilator Agents $w P $a látky vazodilatačné 550 $7 sllk_us_auth*d018696 $Y Neuroprotective Agents $w P $a látky neuroprotektívne 550 $7 sllk_us_auth*d058987 $Y Phosphodiesterase 3 Inhibitors $w P $a inhibítory fosfodiesterázy 3 665 $a 2019 (1985) $2 eng 680 9-
$i A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke. $2 eng 750 -2
$a Cilostazol $2 eng 980 $x M
Number of the records: 1